Drug Trial Radar · NCT00147758
WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Jan 18, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Actual
Start
Jun 2004
Primary completion
Aug 2006
Study completion Aug 2006
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Sep 7, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
Conditions
- Type 2 Diabetes
Interventions
Colesevelam hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the additional lowering of HbA1c achieved by addition of colesevelam hydrochloride to current antidiabetic therapy
Locations
47 sites in 3 countries. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Tuscumbia, Alabama
Site not named
Little Rock, Arkansas
Site not named
Searcy, Arkansas
Site not named
Concord, California
Site not named
Irvine, California
Site not named
La Jolla, California
Site not named
Los Angeles, California
Site not named
Los Gatos, California
Site not named
West Hills, California
Site not named
Coral Gables, Florida
Site not named
Miami, Florida
Site not named
New Port Richey, Florida
Site not named
Pembroke Pines, Florida
Site not named
West Palm Beach, Florida
Site not named
Atlanta, Georgia
Site not named
Chicago, Illinois
Site not named
Indianapolis, Indiana
Site not named
New Orleans, Louisiana
Site not named
Boston, Massachusetts
Site not named
Kansas City, Missouri
Site not named
St Louis, Missouri
Site not named
Rochester, New York
Site not named
Charlotte, North Carolina
Site not named
Hickory, North Carolina
Site not named
Statesville, North Carolina
Site not named
Winston-Salem, North Carolina
Site not named
Cincinnati, Ohio
Site not named
Cleveland, Ohio
Site not named
Marion, Ohio
Site not named
Perrysburg, Ohio
Site not named
Oklahoma City, Oklahoma
Site not named
Tulsa, Oklahoma
Site not named
Portland, Oregon
Site not named
Beaver, Pennsylvania
Site not named
Charleston, South Carolina
Site not named
Bristol, Tennessee
Site not named
Dallas, Texas
Site not named
Houston, Texas
Site not named
Midland, Texas
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.